Literature DB >> 17510964

The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A.

Claudia Borelli1, Elisabeth Ruge, Martin Schaller, Michel Monod, Hans Christian Korting, Robert Huber, Klaus Maskos.   

Abstract

The family of secreted aspartic proteinases (Sap) encoded by 10 SAP genes is an important virulence factor during Candida albicans (C. albicans) infections. Antagonists to Saps could be envisioned to help prevent or treat candidosis in immunocompromised patients. The knowledge of several Sap structures is crucial for inhibitor design; only the structure of Sap2 is known. We report the 1.9 and 2.2 A resolution X-ray crystal structures of Sap3 in a stable complex with pepstatin A and in the absence of an inhibitor, shedding further light on the enzyme inhibitor binding. Inhibitor binding causes active site closure by the movement of a flap segment. Comparison of the structures of Sap3 and Sap2 identifies elements responsible for the specificity of each isoenzyme.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510964     DOI: 10.1002/prot.21425

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  10 in total

1.  Protease expression by microorganisms and its relevance to crucial physiological/pathological events.

Authors:  André Luis Souza Dos Santos
Journal:  World J Biol Chem       Date:  2011-03-26

2.  Candida albicans secreted aspartic proteases 4-6 induce apoptosis of epithelial cells by a novel Trojan horse mechanism.

Authors:  Hao Wu; Deborah Downs; Koena Ghosh; Arun K Ghosh; Peter Staib; Michel Monod; Jordan Tang
Journal:  FASEB J       Date:  2013-02-19       Impact factor: 5.191

3.  HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos.

Authors:  André Luis Souza Dos Santos
Journal:  World J Biol Chem       Date:  2010-02-26

4.  Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin.

Authors:  Jane M Sayer; John M Louis
Journal:  Proteins       Date:  2009-05-15

5.  Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.

Authors:  Jason C Kwan; Erika A Eksioglu; Chen Liu; Valerie J Paul; Hendrik Luesch
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

6.  N-terminal entrance loop of yeast Yps1 and O-glycosylation of substrates are determinant factors controlling the shedding activity of this GPI-anchored endopeptidase.

Authors:  Alexandre K Dubé; Marc Bélanger; Isabelle Gagnon-Arsenault; Yves Bourbonnais
Journal:  BMC Microbiol       Date:  2015-02-26       Impact factor: 3.605

7.  Scalar nanostructure of the Candida albicans cell wall; a molecular, cellular and ultrastructural analysis and interpretation.

Authors:  Megan D Lenardon; Prashant Sood; Helge C Dorfmueller; Alistair J P Brown; Neil A R Gow
Journal:  Cell Surf       Date:  2020-11-08

8.  Identification of novel aspartic proteases from Strongyloides ratti and characterisation of their evolutionary relationships, stage-specific expression and molecular structure.

Authors:  Luciane V Mello; Helen O'Meara; Daniel J Rigden; Steve Paterson
Journal:  BMC Genomics       Date:  2009-12-16       Impact factor: 3.969

9.  Genomic Analyses of Cladophialophora bantiana, a Major Cause of Cerebral Phaeohyphomycosis Provides Insight into Its Lifestyle, Virulence and Adaption in Host.

Authors:  Chee Sian Kuan; Chun Yoong Cham; Gurmit Singh; Su Mei Yew; Yung-Chie Tan; Pei-Sin Chong; Yue Fen Toh; Nadia Atiya; Shiang Ling Na; Kok Wei Lee; Chee-Choong Hoh; Wai-Yan Yee; Kee Peng Ng
Journal:  PLoS One       Date:  2016-08-29       Impact factor: 3.240

10.  Metabolic profiling of Candida clinical isolates of different species and infection sources.

Authors:  Josidel Conceição Oliver; Luca Laghi; Carola Parolin; Claudio Foschi; Antonella Marangoni; Andrea Liberatore; Amanda Latercia Tranches Dias; Monica Cricca; Beatrice Vitali
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.